Browse life science companies in Cambridge, home to one of Europe's leading biotechnology and life science ecosystems.
Fermentation-derived astaxanthin active ingredient for premium natural skincare
Kinva Bio is a UK-based fermentation biotechnology company developing bio-based active ingredients for the skincare industry. The company's first product is a fermentation-derived astaxanthin, a natural antioxidant positioned as a stronger and more scalable alternative to conventional algal-derived astaxanthin. Kinva…
Defined live bacterial consortia for oncology and inflammatory bowel disease
Microbiotica is a clinical-stage biopharmaceutical company developing oral live biotherapeutic products comprising defined consortia of gut commensal bacterial strains. Candidate bacterial strains are identified by analysing microbiome data from clinical outcome studies, enabling mechanistically grounded strain…
Distributor of antibodies and reagents for life science research
Stratech Scientific was a UK distributor of life science research products, including antibodies, reagents, cells and specialist laboratory supplies used in immunology, cell biology, cancer research and neuroscience. On 24 February 2026, Cambridge Bioscience acquired the business. Stratech's products and customer…
Reagents that stabilise and fix RNA, DNA and tissue samples
RNAssist is a reagents company developing patented stabilisation and fixation products for biological samples. Its formulations, based on deep eutectic solvents, preserve RNA, DNA, proteins and cell structure at the point of collection and are compatible with downstream methods such as single-cell sequencing and…
Biomarker-driven CRO integrating clinical trials and laboratory sciences
Precision for Medicine is a full-service contract research organisation built around biomarker-driven clinical development. The company integrates clinical trial execution with specialty laboratory services, translational science, data management, and biostatistics to support oncology, rare disease, and cell and gene…
Enzyme-free multiplex RNA diagnostics for rapid clinical decisions
Cambridge Nucleomics is a biotechnology company developing a proprietary nanopore-based platform for rapid, high-multiplexed detection of nucleic acid biomarkers. Its enzyme-free soluble nanoarray technology enables simultaneous quantification of up to 200 RNA and DNA targets from low-input samples within one hour.…
Global leader in next-generation sequencing and genomic analysis
Illumina is a US-headquartered life science company and the dominant provider of next-generation sequencing platforms and array-based genotyping tools. Its UK operations are based at Granta Park in Cambridge, serving as its primary European research and commercial hub. Illumina's technologies underpin applications in…
Microbial conversion of waste into sustainable aviation fuel feedstock
Neela Biotech develops microbial processes that convert food, agricultural and forestry waste into fatty acids for sustainable aviation fuel production. Its approach combines AI-guided microbes with anaerobic digestion and is designed to integrate into existing biogas plants rather than require entirely new…
Academic-industry translational research institute
The Milner Therapeutics Institute is a University of Cambridge biomedical research institute established to bridge academic science and pharmaceutical drug discovery. Founded in 2015 and based at the Jeffrey Cheah Biomedical Centre on the Cambridge Biomedical Campus, it operates both an in-house research programme and…